Archive for the 'Respiratory diseases' Category

07 Jun

Respiratory and Related Management of Patients With Duchenne Muscular Dystrophy: General Anesthesia or Procedural Sedation (Postoperative)

A. Respiratory Support Extubation directly to NPPV should be considered for DMD patients with baseline FVC < 50% of predicted, and should be strongly considered for those with FVC < 30% of predicted who have been endotracheally intubated for general anesthesia or procedural sedation. Extubation directly to NPPV should also be considered for any patient […]

01 Jun

My Canadian Pharmacy about Respiratory and Related Management of Patients With Duchenne Muscular Dystrophy

A. Choice of Pharmacologic Agents for General Anesthesia Patients with DMD are at increased risk for extreme hyperthermic events and rhabdomyolysis when they are exposed to certain anesthetics, especially inhaled agents such as halothane, isofluorane, and servoflurane. Such episodes can cause hyperkalemia and sudden death from cardiac arrest. These events mimic malignant hyperthermia, but DMD […]

27 May

Respiratory Support and Related Management of Patients With Duchenne Muscular Dystrophy

Methodology and Structure This consensus statement is the product of a panel convened under the auspices of the ACCP Pediatric Chest Medicine and Home Care NetWorks. The panel consists of specialists in the areas of anesthesiology, critical care medicine, neurology, orthopedic surgery, pediatric and adult pulmonology, and respiratory therapy. The panel worked on this project […]

23 May

Background of Respiratory and Related Management of Patients With Duchenne Muscular Dystrophy

DMD is a progressive neuromuscular disease transmitted by X-linked inheritance with an incidence of approximately 1 in 3,500 live male births. DMD affects the muscles of respiration and is associated with dilated cardiomyopathy, which often leads to death from cardiopulmonary causes. With current medical management, including the use of nocturnally assisted ventilation, mean survival now […]

18 May

Executive Summary in Respiratory and Related Management of Patients With Duchenne Muscular Dystrophy

Duchenne muscular dystrophy (DMD) is a progressive neuromuscular disease transmitted by X-linked inheritance with an incidence of approximately 1 in 3,500 live male births. DMD affects the muscles of respiration and is associated with dilated cardiomyopathy, which often leads to death from cardiopulmonary causes. Patients with DMD are especially vulnerable to the adverse physiologic effects […]

© 2008 HIV/AIDS News & Information